U of L researcher, drug company collaborate on stem cells - WDRB 41 Louisville News

U of L researcher, drug company collaborate on stem cells

Posted: Updated:

LOUISVILLE, Ky. (WDRB) -- The University of Louisville is celebrating a move that will help its research program to save lives around the world.

University officials announced Wednesday that renowned U of L researcher Suzanne Ildstad and her company Regenerex have entered into an agreement with pharmaceutical giant Novartis.

It's hoped the move will enable stem-cell technology developed by Ildstad and her team to prevent rejection of kidney transplants to be made available worldwide much sooner.

"We needed to commercialize it to make it widely available. And, we're really optimistic that through the collaboration with Novartis we'll be able to do that. And, it's just fantastic to be planning to have a worldwide initiative and move into a pivotal trial through the kidneys and possibly the metabolics in very short order," Ildstad told reporters.

It's also hoped Novartis will use the U of L research to develop treatments for other diseases.

Copyright 2013 WDRB News.  All rights reserved.

  • Closed CaptioningMore>>

  • Closed Captioning Message

    Thanks to a grant from Norton Healthcare, this story and others are available in real-time closed captioning on WDRB.
    Thanks to a grant from Norton Healthcare, this story and others are available in real-time closed captioning on WDRB.More >>
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WDRB. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.